CAPS (calcyphosine) is a calcium-binding protein localized to the cytosol and vesicles that plays a role in intracellular signal transduction [GO Annotations]. However, the provided PubMed abstracts do not contain direct information about calcyphosine protein function. The abstracts primarily address CAPS as an acronym for cryopyrin-associated periodic syndrome, a rare autoinflammatory disorder caused by gain-of-function mutations in the NLRP3 gene, not the CAPS protein itself 12. In CAPS disease, mutant NLRP3 leads to aberrant inflammasome activation and excessive IL-1β secretion, causing systemic inflammation affecting skin, joints, and the central nervous system 13. Recent mechanistic studies reveal that PIEZO-mediated mechanotransduction activates the NLRP3 inflammasome through KCNN4-dependent potassium efflux, and this pathway is particularly dysregulated in cells carrying CAPS-causing NLRP3 mutations 4. Additionally, HSP90β chaperone complex activity is essential for NLRP3 autoactivation in CAPS 5. Current therapeutic strategies targeting IL-1 or inflammasome components have significantly improved outcomes for CAPS patients 3. To provide an accurate functional summary of the calcyphosine protein itself, additional literature specifically addressing calcyphosine's molecular mechanisms would be necessary.